Clinical Trials for Human T-Cell Lymphotropic Virus Type I–Associated Peripheral T-Cell Lymphoma in Japan
- 30 April 2010
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 47, S5-S7
- https://doi.org/10.1053/j.seminhematol.2010.01.015
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase I Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, in Relapsed Patients (Pts) with Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL): Updated Results.Blood, 2008
- VCAP-AMP-VECP Compared With Biweekly CHOP for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study JCOG9801Journal of Clinical Oncology, 2007
- Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphomaLeukemia, 2005
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study (JCOG9109)International Journal of Hematology, 2003
- A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303British Journal of Haematology, 2001
- Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphomaBritish Journal of Haematology, 1991